23andMe had all the signs of a success story. The Pretty Ex-Girlfriendunicorn brand became synonymous with consumer-facing genetic testing, went public, and was once valued at $6 billion.
But then, it all came tumbling down. Sales for 23AndMe kits began to fall, attempts to raise new funds hit a wall, the company struggled to find a product that would bring in recurring revenue, and it was still dealing with the fallout from a major data breach.
23andMe filed for bankruptcyand put its assets up for salein March 2025. But, more concerning than the success or failure of a particular company, was this question: What would happen to 23andMe's vast trove of highly personal customer data? We aren't just talking about usernames and birthdays. 23andMe has DNA profilesfor millions of users.
Well, now we know who bought 23andMe and, most importantly, now owns all the DNA data from the company's customers.
On Monday, Regeneron Pharmaceuticals announcedthat it would acquire most of 23andMe's assets for $256 million. According to Regeneron Pharmaceuticals, the acquisition includes 23andMe's Personal Genome Service, Total Health and Research Services business lines, and the trove of customers' DNA samples and genetic data.
This Tweet is currently unavailable. It might be loading or has been removed.
Regeneron Pharmaceuticals will not, however, be acquiring 23andMe's online doctor and telehealth service known as Lemonaid Health, which will be shuttered.
Based in Tarrytown, NY, Regeneron Pharmaceuticals is a biotechnology company that researches and develops medicines for cancer, cardiovascular disease, and other diseases. The company is currently valued at more than $64 billion.
Regeneron Pharmaceuticals placed a bid for 23andMe as part of a court-supervised sales process. The bid requires Regeneron Pharmaceuticals to comply with the company's existing privacy policies and applicable laws.
Conspiracy-minded consumers might revolt at the idea of a big pharma brand acquiring their DNA profile. However, in a press release, Regeneron has promised "to comply with the Company’s privacy policies" and "process all customer personal data in accordance with the consents, privacy policies and statements, terms of service, and notices currently in effect." Further, the company assured customers it has "a proven track record of safeguarding personal genetic data, and we assure 23andMe customers that we will apply our high standards for safety and integrity to their data." A court-appointed expert will also submit a report about potential privacy and security impacts to the court by June 10.
If the name "Regeneron" sounds familiar, it may be because the company received mainstream attention in 2020 after the company created an experimental treatment for COVID-19 called REGN-COV2. President Donald Trump was treated with the drug when he was infected with COVID-19 in October of that year.
While 23andMe's demise is certainly notable, a most lasting debate will undoubtedly be had regarding the sale of 15 million customers' genetic data.
“Your DNA and your family health history should not be a corporate asset," said J.B. Branch, Big Tech accountability advocate for the consumer rights advocacy group Public Citizen, in a statement. "Of course, Regeneron will promise to ‘respect consent’ and ‘uphold privacy policies.’ Those are bare minimal legal requirements. But time and again these companies fail consumers."
Topics Cybersecurity Politics
Politics, Nerds, Gunpowder by Sadie SteinBiden asks Trump what everyone's thinking: 'Will you shut up, man?'Buy 1 Get 50% 1 for dog Halloween costumes and apparel at PetcoMagic Hour: An Interview with Gregory Crewdson by Elisabeth Donnelly'Doomswiping' is the latest pandemic coping mechanismEmma Chamberlain talks coffee, YouTube drama, and quarantine lonelinessIn Which the Author Reads the Works of Albert Cossery: An Illustrated Essay, Part 2 by Nathan GelgudArthurian Legend, Literary Restaurants by Sadie SteinShades of Red: On Indian Summer by Maria KonnikovaTwitter is now worth oneBooks for Readers, Nonreaders by Sadie SteinDonald Trump tweets that he and Melania have tested positive for COVIDPoetic Prescriptions, Banished Words by Sadie SteinZagat, Library Science, Cheap Thrills by Sadie SteinZagat, Library Science, Cheap Thrills by Sadie Stein'Quordle' today: See each 'Quordle' answer and hints for May 31An Object Lesson: Beware of Getting Out of Touch by The Paris ReviewWordle today: Here's the answer and hints for May 30The Flanders Duck by Cody UptonWill Oldham on Bonnie “Prince” Billy by Alan Licht Justin Trudeau met the Queen of England to the internet's delight Pixel 4a 5G renders show a familiar design, with 1 surprise Cardi B and Megan Thee Stallion are giving away $1 million to celebrate "WAP" Hackers can now clone your keys just by listening to them with a smartphone RealFarmacy is the top source of health misinformation on Facebook Teslas might get a sensor that detects a child left in a hot car Hobby Lobby buying smuggled Iraqi artifacts is too much for the internet to handle United is now literally taking things from children Jerk bear gets woman arrested in Alaska Apple is now the first U.S. company to be worth $2 trillion dollars Instagrammers are staging fake camping pictures, and this account is calling them out 9 in 10 republicans think social media sites censor political views Sega’s Dreamcast is the unsung gaming hero of the 2000s Londoner creates very unusual snack, gets reported to police HBO's 'The Vow' is a cautionary look at the NXIVM cult's downfall Apocalypse films of the 2000s: What the end of the world looked like Your laptop is now allowed on U.S. flights from Dubai and Istanbul Ryan Reynolds helps teen get over her ex with some perfect Photoshop advice How to get police out of schools, and why it matters Lena Dunham describes painful decision to re
2.6609s , 8223.890625 kb
Copyright © 2025 Powered by 【Pretty Ex-Girlfriend】,Feast Information Network